Form 4 for XERS Xeris Biopharma Holdings, Inc.
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-13 · accession 0001867096-22-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-14 | 2022-12-13 | XERS | Edick Paul R | See Remarks, Dir | P - Purchase | $1.45 | +20.0K | 1.53M | +1% | +$29.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-13 | P | A | 20,000 | $1.45 | 1,528,064 | D | — | — |